ANG Lifesciences India Ltd
ANG Lifesciences India Ltd Live Price Chart
ANG Lifesciences India Ltd Technicals
| 20 Day | ₹ 25.607 |
| 50 Day | ₹ 27.085 |
| 100 Day | ₹ 28.520 |
| 200 Day | ₹ 31.047 |
| 20 Day | ₹ 25.078 |
| 50 Day | ₹ 27.656 |
| 100 Day | ₹ 29.769 |
| 200 Day | ₹ 29.307 |
ANG Lifesciences India Ltd Performance
| Previous Close | ₹ 26.71 |
| High | ₹ 27.5 |
| Volume | 3364 |
| 52W Range | ₹ 21.03 - ₹ 42.78 |
| Open | ₹ 27.5 |
| Low | ₹ 24.52 |
| Market Cap | ₹ 38 Cr |
ANG Lifesciences India Ltd Fundamentals
| ROCE | -2.236 |
| P/E Ratio | -4.240 |
| P/B Ratio | 0.530 |
| Industry P/E | 0.530 |
| Debt to Equity | 39.451 |
| ROE | -12.398 |
| EPS | -6.200 |
| Dividend Yield | 0.000 |
| Book Value | 49.977 |
| Face Value | 10.000 |
ANG Lifesciences India Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 92.3541 | 132.204 | 216.8479 | 349.6209 | 154.9348301 |
| Total Expenses | 105.2915 | 139.3363 | 214.7787 | 296.5573 | 144.7957541 |
| Profit After Tax | -10.3429 | -8.6481 | -0.6622 | 39.713 | 7.0276305 |
ANG Lifesciences India Ltd Shareholding Pattern
| Promoter Holdings | 70.603 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 26.184 % |
| Others - | 3.213 % |
About ANG Lifesciences India Ltd
History of ANG Lifesciences India Ltd
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name 'ANG Lifesciences India Private Limited' on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to 'ANG Lifesciences India Private Limited' on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to 'ANG Lifesciences India Limited' on May 18, 2016. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 2008-09, the Company started its commercial production. In 2014-15, it commenced direct sale of medicines covering hospitals , Doctors through stockists. The Company is ISO-9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum & Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing set-up consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These state-of-art facilities have integrated process development teams with in-house engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical eq ...
